[Significance of progestins in treatment of endometriosis].

Zentralblatt fur Gynakologie · 1997 · vol. 119 Suppl 2 , pp. 64–9 · PMID:9441544 · W2409427683
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed

Abstract

Endometriosis is a chronic benign proliferative disease with high risk of recurrences, despite of medical and/or surgical treatment. The variation and severity of symptoms reduce the quality of life, the ability of working and the sexual behaviour. Medical cure of symptoms is a central concept in the therapeutic strategy. Low dose progestins have shown to be effective in the clinical routine since several decades although scientific data are rare and insufficient about the mechanism of action of these substances. Subjective and biochemical side effects are important for the choice of a specific progestin. The dosage is dependent of the biological activity of the drug, especially the effect on the endometrium. On the endometriotic implants and cysts high dose therapy with progestins induces the same regressive changes as complete estrogen deprivation by reversible "medical castration".

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Progesterone Congeners Cell Division Cell Division Cell Division Dose-Response Relationship, Drug Endometriosis Endometriosis Endometrium Endometrium Endometrium Female Humans Progesterone Congeners Progesterone Congeners Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:52.568893+00:00
License: CC0 · commercial use OK